1. Home
  2. ABLV vs RVPH Comparison

ABLV vs RVPH Comparison

Compare ABLV & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABLV
  • RVPH
  • Stock Information
  • Founded
  • ABLV 2015
  • RVPH 2006
  • Country
  • ABLV China
  • RVPH United States
  • Employees
  • ABLV N/A
  • RVPH N/A
  • Industry
  • ABLV
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABLV
  • RVPH Health Care
  • Exchange
  • ABLV Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • ABLV 38.1M
  • RVPH 33.4M
  • IPO Year
  • ABLV N/A
  • RVPH N/A
  • Fundamental
  • Price
  • ABLV $0.65
  • RVPH $1.56
  • Analyst Decision
  • ABLV
  • RVPH Strong Buy
  • Analyst Count
  • ABLV 0
  • RVPH 4
  • Target Price
  • ABLV N/A
  • RVPH $15.33
  • AVG Volume (30 Days)
  • ABLV 18.1K
  • RVPH 4.3M
  • Earning Date
  • ABLV 01-01-0001
  • RVPH 11-14-2024
  • Dividend Yield
  • ABLV N/A
  • RVPH N/A
  • EPS Growth
  • ABLV 18.07
  • RVPH N/A
  • EPS
  • ABLV 0.24
  • RVPH N/A
  • Revenue
  • ABLV $148,999,819.00
  • RVPH N/A
  • Revenue This Year
  • ABLV N/A
  • RVPH N/A
  • Revenue Next Year
  • ABLV N/A
  • RVPH N/A
  • P/E Ratio
  • ABLV $3.07
  • RVPH N/A
  • Revenue Growth
  • ABLV 2.58
  • RVPH N/A
  • 52 Week Low
  • ABLV $0.55
  • RVPH $0.60
  • 52 Week High
  • ABLV $3.94
  • RVPH $5.67
  • Technical
  • Relative Strength Index (RSI)
  • ABLV 45.41
  • RVPH 48.70
  • Support Level
  • ABLV $0.55
  • RVPH $1.25
  • Resistance Level
  • ABLV $0.77
  • RVPH $4.28
  • Average True Range (ATR)
  • ABLV 0.07
  • RVPH 0.47
  • MACD
  • ABLV -0.01
  • RVPH -0.01
  • Stochastic Oscillator
  • ABLV 48.83
  • RVPH 14.65

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: